The UK's Obesity Crisis: New Government Strategy and What It Means
The government has set out its most comprehensive obesity strategy in over a decade, pledging to reduce adult obesity rates by 2035 through a combination of expanded NHS treatment, tighter food marketing regulations and a renewed focus on preventive health. The plan, which draws on modelling by the Office for Health Inequalities and Disparities, acknowledges what public health campaigners have argued for years: that willpower alone cannot explain a crisis affecting more than a quarter of all English adults.
The Scale of the Problem
According to figures from NHS England, obesity-related conditions now account for an estimated £6.5 billion in NHS expenditure every year. Factor in lost productivity, increased social care demand and the downstream effects on conditions from type 2 diabetes to certain cancers, and the Office for Health Inequalities and Disparities puts the wider economic toll at more than £27 billion annually.
The statistics are stark in their social dimension too. Obesity rates in the most deprived areas of England are roughly double those in the least deprived, a disparity that has widened over the past fifteen years. Children in low-income households are significantly more likely to leave primary school overweight or obese — a predictor, researchers consistently find, of chronic ill health in adulthood. Any serious obesity strategy, campaigners argue, must confront these inequalities head-on rather than treating the condition as a matter of individual choice.
What the New Strategy Contains
The strategy is built around three broad pillars: expanding access to medical treatment, reforming the food environment, and investing in community-level prevention.
On treatment, the most eye-catching element is the broadening of NHS pathways for GLP-1 receptor agonists — a class of injectable weight-loss drugs that includes semaglutide, marketed under the brand names Ozempic and Wegovy. As reported by the BBC, demand for these medications has surged dramatically since their effectiveness for weight management was established in clinical trials, with some patients losing more than 15 per cent of their body weight over the course of treatment. The strategy commits to expanding specialist weight-management services to accommodate a larger patient population, though eligibility will continue to be governed by NICE guidance, which currently requires a BMI of 35 or above alongside at least one related health condition.
The food environment measures are more cautious. The strategy proposes extending restrictions on advertising high-fat, salt and sugar (HFSS) products before the 9pm watershed — a policy already legislated but unevenly enforced — and consulting on further limits on price promotions in supermarkets. The Healthy Start scheme, which provides vouchers for pregnant women and families with young children to spend on fruit, vegetables and milk, is to be extended in scope, though campaigners had lobbied for an increase in the voucher value, which has not kept pace with food price inflation.
What Critics Are Saying
The reaction from public health bodies has been mixed. The Health Foundation welcomed the commitment to NHS investment but warned that without structural reform of the food industry — mandatory reformulation targets, for instance, rather than voluntary pledges — the strategy risks treating symptoms rather than causes. Anti-poverty groups have been more pointed: the Joseph Rowntree Foundation noted that food insecurity, which affects millions of households following years of elevated prices, is itself a driver of poor dietary choices, and that no obesity strategy can succeed unless it addresses the affordability of nutritious food.
Clinicians, meanwhile, have raised practical concerns about the GLP-1 expansion. Supply shortages have periodically disrupted prescribing over the past two years, and there are legitimate questions about what happens when patients stop taking the medication — evidence suggests significant weight regain is common without ongoing behavioural support. Some GPs have expressed concern that the strategy's headline focus on drugs may come at the expense of investment in community dietetics and weight-management counselling, which remain chronically underfunded.
The Role of Prevention
Perhaps the most consequential aspect of the strategy — and the one that will take longest to bear fruit — is its emphasis on prevention in childhood and early adulthood. The plan includes commitments to strengthen the Healthy Schools programme, expand access to physical activity in state schools and pilot community-based programmes in areas with the highest rates of childhood obesity.
There is also a renewed focus on the built environment: planning guidance is to be updated to encourage local authorities to limit the density of fast-food outlets near schools, a measure that a growing body of evidence suggests can influence dietary behaviour. Whether local councils, many of which are managing severe budget pressures, will have the resources to implement such guidance consistently remains an open question.
The strategy sets a headline ambition of reducing adult obesity prevalence by five percentage points by 2035. Independent health economists have described this target as achievable but stretching — and only if the full package of measures is implemented rather than selectively adopted.
The Bigger Picture
The UK is not alone in grappling with rising obesity rates, but it faces a particular challenge in reconciling public health ambition with fiscal constraint. The NHS is under sustained pressure, and the promise of expanded treatment access will need to be matched by genuine resource allocation rather than aspirational language.
What the new strategy does represent, however, is a shift in political tone. Where previous iterations of government obesity policy leaned heavily on personal responsibility — a framing that critics argued both stigmatised individuals and ignored structural realities — this iteration at least acknowledges the systemic nature of the problem. Whether acknowledgement translates into the kind of sustained, cross-departmental commitment that meaningful change requires will be the true measure of its success.
For millions of people living with obesity in the UK, the stakes could scarcely be higher.